| GO:0010518 | positive regulation of phospholipase activity | 25.0% (1/4) | 9.8 | 0.001125 | 0.012076 |
| GO:0030061 | mitochondrial crista | 25.0% (1/4) | 9.8 | 0.001125 | 0.012076 |
| GO:0039519 | modulation by virus of host autophagy | 25.0% (1/4) | 9.8 | 0.001125 | 0.012076 |
| GO:0044830 | modulation by host of viral RNA genome replication | 25.0% (1/4) | 9.8 | 0.001125 | 0.012076 |
| GO:0052040 | modulation by symbiont of host programmed cell death | 25.0% (1/4) | 9.8 | 0.001125 | 0.012076 |
| GO:0060193 | positive regulation of lipase activity | 25.0% (1/4) | 9.8 | 0.001125 | 0.012076 |
| GO:0075044 | positive regulation by symbiont of host autophagy | 25.0% (1/4) | 9.8 | 0.001125 | 0.012076 |
| GO:0075071 | modulation by symbiont of host autophagy | 25.0% (1/4) | 9.8 | 0.001125 | 0.012076 |
| GO:1904092 | regulation of autophagic cell death | 25.0% (1/4) | 9.8 | 0.001125 | 0.012076 |
| GO:2000322 | regulation of glucocorticoid receptor signaling pathway | 25.0% (1/4) | 9.8 | 0.001125 | 0.012076 |
| GO:0031315 | extrinsic component of mitochondrial outer membrane | 25.0% (1/4) | 9.67 | 0.001227 | 0.012719 |
| GO:0033599 | regulation of mammary gland epithelial cell proliferation | 25.0% (1/4) | 9.67 | 0.001227 | 0.012719 |
| GO:0010517 | regulation of phospholipase activity | 25.0% (1/4) | 9.55 | 0.00133 | 0.01289 |
| GO:0031536 | positive regulation of exit from mitosis | 25.0% (1/4) | 9.55 | 0.00133 | 0.01289 |
| GO:0060766 | negative regulation of androgen receptor signaling pathway | 25.0% (1/4) | 9.55 | 0.00133 | 0.01289 |
| GO:0098982 | GABA-ergic synapse | 25.0% (1/4) | 9.55 | 0.00133 | 0.01289 |
| GO:0044571 | [2Fe-2S] cluster assembly | 25.0% (1/4) | 9.45 | 0.001432 | 0.01324 |
| GO:0032660 | regulation of interleukin-17 production | 25.0% (1/4) | 9.45 | 0.001432 | 0.01324 |
| GO:1900871 | chloroplast mRNA modification | 25.0% (1/4) | 9.45 | 0.001432 | 0.01324 |
| GO:0002753 | cytoplasmic pattern recognition receptor signaling pathway | 25.0% (1/4) | 9.93 | 0.001023 | 0.013365 |
| GO:0035902 | response to immobilization stress | 25.0% (1/4) | 9.93 | 0.001023 | 0.013365 |
| GO:0039520 | induction by virus of host autophagy | 25.0% (1/4) | 9.93 | 0.001023 | 0.013365 |
| GO:0039528 | cytoplasmic pattern recognition receptor signaling pathway in response to virus | 25.0% (1/4) | 9.93 | 0.001023 | 0.013365 |
| GO:0039529 | RIG-I signaling pathway | 25.0% (1/4) | 9.93 | 0.001023 | 0.013365 |
| GO:0060444 | branching involved in mammary gland duct morphogenesis | 25.0% (1/4) | 9.93 | 0.001023 | 0.013365 |
| GO:1900208 | regulation of cardiolipin metabolic process | 25.0% (1/4) | 9.93 | 0.001023 | 0.013365 |
| GO:0042750 | hibernation | 25.0% (1/4) | 9.93 | 0.001023 | 0.013365 |
| GO:0007202 | activation of phospholipase C activity | 25.0% (1/4) | 10.25 | 0.000818 | 0.014467 |
| GO:0010863 | positive regulation of phospholipase C activity | 25.0% (1/4) | 10.25 | 0.000818 | 0.014467 |
| GO:0010944 | negative regulation of transcription by competitive promoter binding | 25.0% (1/4) | 10.25 | 0.000818 | 0.014467 |
| GO:0030421 | defecation | 25.0% (1/4) | 10.25 | 0.000818 | 0.014467 |
| GO:0060749 | mammary gland alveolus development | 25.0% (1/4) | 10.25 | 0.000818 | 0.014467 |
| GO:0098891 | extrinsic component of presynaptic active zone membrane | 25.0% (1/4) | 10.25 | 0.000818 | 0.014467 |
| GO:0140374 | antiviral innate immune response | 25.0% (1/4) | 10.25 | 0.000818 | 0.014467 |
| GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway | 25.0% (1/4) | 10.25 | 0.000818 | 0.014467 |
| GO:0000423 | mitophagy | 25.0% (1/4) | 10.08 | 0.000921 | 0.014562 |
| GO:0045745 | positive regulation of G protein-coupled receptor signaling pathway | 25.0% (1/4) | 10.08 | 0.000921 | 0.014562 |
| GO:1900274 | regulation of phospholipase C activity | 25.0% (1/4) | 10.08 | 0.000921 | 0.014562 |
| GO:1905330 | regulation of morphogenesis of an epithelium | 25.0% (1/4) | 10.08 | 0.000921 | 0.014562 |
| GO:0060191 | regulation of lipase activity | 25.0% (1/4) | 9.25 | 0.001636 | 0.014679 |
| GO:0098888 | extrinsic component of presynaptic membrane | 25.0% (1/4) | 9.25 | 0.001636 | 0.014679 |
| GO:0007096 | regulation of exit from mitosis | 25.0% (1/4) | 9.17 | 0.001739 | 0.015366 |
| GO:0099243 | extrinsic component of synaptic membrane | 25.0% (1/4) | 9.08 | 0.001841 | 0.016034 |
| GO:0031314 | extrinsic component of mitochondrial inner membrane | 25.0% (1/4) | 8.93 | 0.002045 | 0.01661 |
| GO:0000001 | mitochondrion inheritance | 25.0% (1/4) | 8.93 | 0.002045 | 0.01661 |
| GO:0002250 | adaptive immune response | 25.0% (1/4) | 8.93 | 0.002045 | 0.01661 |
| GO:0002460 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 25.0% (1/4) | 8.93 | 0.002045 | 0.01661 |
| GO:2000027 | regulation of animal organ morphogenesis | 25.0% (1/4) | 9.01 | 0.001943 | 0.016682 |
| GO:0016783 | sulfurtransferase activity | 25.0% (1/4) | 8.86 | 0.002147 | 0.01676 |
| GO:0050680 | negative regulation of epithelial cell proliferation | 25.0% (1/4) | 8.86 | 0.002147 | 0.01676 |
| GO:1901987 | regulation of cell cycle phase transition | 50.0% (2/4) | 5.49 | 0.00073 | 0.016886 |
| GO:0002922 | positive regulation of humoral immune response | 25.0% (1/4) | 8.8 | 0.00225 | 0.016899 |
| GO:0046718 | viral entry into host cell | 25.0% (1/4) | 8.8 | 0.00225 | 0.016899 |
| GO:0071300 | cellular response to retinoic acid | 25.0% (1/4) | 8.8 | 0.00225 | 0.016899 |
| GO:0010564 | regulation of cell cycle process | 50.0% (2/4) | 4.71 | 0.002128 | 0.017049 |
| GO:0001552 | ovarian follicle atresia | 25.0% (1/4) | 10.45 | 0.000716 | 0.017217 |
| GO:0001846 | opsonin binding | 25.0% (1/4) | 10.45 | 0.000716 | 0.017217 |
| GO:0001848 | complement binding | 25.0% (1/4) | 10.45 | 0.000716 | 0.017217 |
| GO:0001850 | complement component C3a binding | 25.0% (1/4) | 10.45 | 0.000716 | 0.017217 |
| GO:0001851 | complement component C3b binding | 25.0% (1/4) | 10.45 | 0.000716 | 0.017217 |
| GO:0023035 | CD40 signaling pathway | 25.0% (1/4) | 10.45 | 0.000716 | 0.017217 |
| GO:0030449 | regulation of complement activation | 25.0% (1/4) | 10.45 | 0.000716 | 0.017217 |
| GO:0031871 | proteinase activated receptor binding | 25.0% (1/4) | 10.45 | 0.000716 | 0.017217 |
| GO:0032740 | positive regulation of interleukin-17 production | 25.0% (1/4) | 10.45 | 0.000716 | 0.017217 |
| GO:0035632 | mitochondrial prohibitin complex | 25.0% (1/4) | 10.45 | 0.000716 | 0.017217 |
| GO:0045917 | positive regulation of complement activation | 25.0% (1/4) | 10.45 | 0.000716 | 0.017217 |
| GO:0050847 | progesterone receptor signaling pathway | 25.0% (1/4) | 10.45 | 0.000716 | 0.017217 |
| GO:0072538 | T-helper 17 type immune response | 25.0% (1/4) | 10.45 | 0.000716 | 0.017217 |
| GO:1990051 | activation of protein kinase C activity | 25.0% (1/4) | 10.45 | 0.000716 | 0.017217 |
| GO:1902806 | regulation of cell cycle G1/S phase transition | 50.0% (2/4) | 7.32 | 5.8e-05 | 0.017349 |
| GO:0022600 | digestive system process | 25.0% (1/4) | 8.61 | 0.002556 | 0.017456 |
| GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway | 25.0% (1/4) | 8.61 | 0.002556 | 0.017456 |
| GO:0070373 | negative regulation of ERK1 and ERK2 cascade | 25.0% (1/4) | 8.61 | 0.002556 | 0.017456 |
| GO:1904732 | regulation of electron transfer activity | 25.0% (1/4) | 8.61 | 0.002556 | 0.017456 |
| GO:0001558 | regulation of cell growth | 50.0% (2/4) | 4.57 | 0.002589 | 0.017484 |
| GO:0044409 | entry into host | 25.0% (1/4) | 8.67 | 0.002454 | 0.017557 |
| GO:0046625 | sphingolipid binding | 25.0% (1/4) | 8.67 | 0.002454 | 0.017557 |
| GO:1904959 | regulation of cytochrome-c oxidase activity | 25.0% (1/4) | 8.67 | 0.002454 | 0.017557 |
| GO:0031312 | extrinsic component of organelle membrane | 50.0% (2/4) | 7.81 | 2.9e-05 | 0.017608 |
| GO:0008277 | regulation of G protein-coupled receptor signaling pathway | 25.0% (1/4) | 8.45 | 0.002862 | 0.017735 |
| GO:0019054 | modulation by virus of host cellular process | 25.0% (1/4) | 8.45 | 0.002862 | 0.017735 |
| GO:0048754 | branching morphogenesis of an epithelial tube | 25.0% (1/4) | 8.45 | 0.002862 | 0.017735 |
| GO:0051897 | positive regulation of protein kinase B signaling | 25.0% (1/4) | 8.45 | 0.002862 | 0.017735 |
| GO:0070181 | small ribosomal subunit rRNA binding | 25.0% (1/4) | 8.45 | 0.002862 | 0.017735 |
| GO:0031329 | regulation of cellular catabolic process | 50.0% (2/4) | 4.62 | 0.002412 | 0.017899 |
| GO:0044068 | modulation by symbiont of host cellular process | 25.0% (1/4) | 8.4 | 0.002964 | 0.017996 |
| GO:0048308 | organelle inheritance | 25.0% (1/4) | 8.4 | 0.002964 | 0.017996 |
| GO:0001541 | ovarian follicle development | 25.0% (1/4) | 8.5 | 0.00276 | 0.018032 |
| GO:0070374 | positive regulation of ERK1 and ERK2 cascade | 25.0% (1/4) | 8.5 | 0.00276 | 0.018032 |
| GO:1901224 | positive regulation of NIK/NF-kappaB signaling | 25.0% (1/4) | 8.5 | 0.00276 | 0.018032 |
| GO:0007588 | excretion | 25.0% (1/4) | 8.35 | 0.003067 | 0.018248 |
| GO:0044827 | modulation by host of viral genome replication | 25.0% (1/4) | 8.35 | 0.003067 | 0.018248 |
| GO:0002920 | regulation of humoral immune response | 25.0% (1/4) | 8.3 | 0.003169 | 0.018311 |
| GO:0061138 | morphogenesis of a branching epithelium | 25.0% (1/4) | 8.3 | 0.003169 | 0.018311 |
| GO:0098586 | cellular response to virus | 25.0% (1/4) | 8.3 | 0.003169 | 0.018311 |
| GO:0010628 | positive regulation of gene expression | 50.0% (2/4) | 4.41 | 0.003217 | 0.018415 |
| GO:0060765 | regulation of androgen receptor signaling pathway | 25.0% (1/4) | 8.21 | 0.003373 | 0.019123 |
| GO:0002637 | regulation of immunoglobulin production | 25.0% (1/4) | 8.08 | 0.003679 | 0.019227 |
| GO:0033144 | negative regulation of intracellular steroid hormone receptor signaling pathway | 25.0% (1/4) | 8.08 | 0.003679 | 0.019227 |
| GO:0044788 | modulation by host of viral process | 25.0% (1/4) | 8.08 | 0.003679 | 0.019227 |
| GO:0048311 | mitochondrion distribution | 25.0% (1/4) | 8.08 | 0.003679 | 0.019227 |
| GO:0070741 | response to interleukin-6 | 25.0% (1/4) | 8.17 | 0.003475 | 0.019337 |
| GO:0071354 | cellular response to interleukin-6 | 25.0% (1/4) | 8.17 | 0.003475 | 0.019337 |
| GO:0000422 | autophagy of mitochondrion | 25.0% (1/4) | 8.13 | 0.003577 | 0.019367 |
| GO:0002639 | positive regulation of immunoglobulin production | 25.0% (1/4) | 8.13 | 0.003577 | 0.019367 |
| GO:0061726 | mitochondrion disassembly | 25.0% (1/4) | 8.13 | 0.003577 | 0.019367 |
| GO:0032526 | response to retinoic acid | 25.0% (1/4) | 8.04 | 0.003781 | 0.01959 |
| GO:0009894 | regulation of catabolic process | 50.0% (2/4) | 4.27 | 0.003911 | 0.01992 |
| GO:0033146 | regulation of intracellular estrogen receptor signaling pathway | 25.0% (1/4) | 8.01 | 0.003883 | 0.019947 |
| GO:0061912 | selective autophagy | 25.0% (1/4) | 7.97 | 0.003985 | 0.019959 |
| GO:1901222 | regulation of NIK/NF-kappaB signaling | 25.0% (1/4) | 7.97 | 0.003985 | 0.019959 |
| GO:0010155 | regulation of proton transport | 25.0% (1/4) | 7.93 | 0.004087 | 0.020301 |
| GO:0051896 | regulation of protein kinase B signaling | 25.0% (1/4) | 7.9 | 0.004189 | 0.020637 |
| GO:0051247 | positive regulation of protein metabolic process | 50.0% (2/4) | 4.2 | 0.004251 | 0.020771 |
| GO:0048661 | positive regulation of smooth muscle cell proliferation | 25.0% (1/4) | 7.8 | 0.004495 | 0.021787 |
| GO:0032147 | activation of protein kinase activity | 25.0% (1/4) | 7.76 | 0.004597 | 0.021928 |
| GO:0051726 | regulation of cell cycle | 50.0% (2/4) | 4.15 | 0.004572 | 0.02198 |
| GO:0048660 | regulation of smooth muscle cell proliferation | 25.0% (1/4) | 7.73 | 0.004699 | 0.022064 |
| GO:1902808 | positive regulation of cell cycle G1/S phase transition | 25.0% (1/4) | 7.73 | 0.004699 | 0.022064 |
| GO:0030518 | intracellular steroid hormone receptor signaling pathway | 25.0% (1/4) | 7.67 | 0.004903 | 0.022668 |
| GO:0070372 | regulation of ERK1 and ERK2 cascade | 25.0% (1/4) | 7.67 | 0.004903 | 0.022668 |
| GO:1903725 | regulation of phospholipid metabolic process | 25.0% (1/4) | 7.61 | 0.005107 | 0.02343 |
| GO:0016575 | histone deacetylation | 25.0% (1/4) | 7.53 | 0.005413 | 0.024645 |
| GO:0006476 | protein deacetylation | 25.0% (1/4) | 7.47 | 0.005617 | 0.025191 |
| GO:0034063 | stress granule assembly | 25.0% (1/4) | 7.47 | 0.005617 | 0.025191 |
| GO:0019048 | modulation by virus of host process | 25.0% (1/4) | 7.45 | 0.005719 | 0.025458 |
| GO:0005747 | mitochondrial respiratory chain complex I | 25.0% (1/4) | 7.37 | 0.006024 | 0.026236 |
| GO:0030964 | NADH dehydrogenase complex | 25.0% (1/4) | 7.37 | 0.006024 | 0.026236 |
| GO:0045271 | respiratory chain complex I | 25.0% (1/4) | 7.37 | 0.006024 | 0.026236 |
| GO:0050678 | regulation of epithelial cell proliferation | 25.0% (1/4) | 7.35 | 0.006126 | 0.026488 |
| GO:0044003 | modulation by symbiont of host process | 25.0% (1/4) | 7.32 | 0.006228 | 0.026736 |
| GO:0016226 | iron-sulfur cluster assembly | 25.0% (1/4) | 7.3 | 0.00633 | 0.02679 |
| GO:0031163 | metallo-sulfur cluster assembly | 25.0% (1/4) | 7.3 | 0.00633 | 0.02679 |
| GO:0042113 | B cell activation | 25.0% (1/4) | 7.28 | 0.006432 | 0.027031 |
| GO:0048026 | positive regulation of mRNA splicing, via spliceosome | 25.0% (1/4) | 7.23 | 0.006635 | 0.027693 |
| GO:0048255 | mRNA stabilization | 25.0% (1/4) | 7.21 | 0.006737 | 0.027924 |
| GO:0032991 | protein-containing complex | 75.0% (3/4) | 2.6 | 0.006852 | 0.028207 |
| GO:0016782 | transferase activity, transferring sulphur-containing groups | 25.0% (1/4) | 7.15 | 0.007043 | 0.028217 |
| GO:0002702 | positive regulation of production of molecular mediator of immune response | 25.0% (1/4) | 7.15 | 0.007043 | 0.028217 |
| GO:0035601 | protein deacylation | 25.0% (1/4) | 7.15 | 0.007043 | 0.028217 |
| GO:0007062 | sister chromatid cohesion | 25.0% (1/4) | 7.1 | 0.007246 | 0.028464 |
| GO:0051851 | modulation by host of symbiont process | 25.0% (1/4) | 7.1 | 0.007246 | 0.028464 |
| GO:0030371 | translation repressor activity | 25.0% (1/4) | 7.1 | 0.007246 | 0.028464 |
| GO:0005768 | endosome | 50.0% (2/4) | 3.84 | 0.006986 | 0.028563 |
| GO:0098732 | macromolecule deacylation | 25.0% (1/4) | 7.08 | 0.007348 | 0.028676 |
| GO:0050685 | positive regulation of mRNA processing | 25.0% (1/4) | 7.06 | 0.00745 | 0.028886 |
| GO:0051253 | negative regulation of RNA metabolic process | 50.0% (2/4) | 3.77 | 0.00766 | 0.029512 |
| GO:1902373 | negative regulation of mRNA catabolic process | 25.0% (1/4) | 7.01 | 0.007755 | 0.029686 |
| GO:0001664 | G protein-coupled receptor binding | 25.0% (1/4) | 6.97 | 0.007958 | 0.029708 |
| GO:0002700 | regulation of production of molecular mediator of immune response | 25.0% (1/4) | 6.97 | 0.007958 | 0.029708 |
| GO:0044000 | movement in host | 25.0% (1/4) | 6.97 | 0.007958 | 0.029708 |
| GO:0035821 | modulation of process of another organism | 25.0% (1/4) | 6.99 | 0.007857 | 0.029885 |
| GO:0031100 | animal organ regeneration | 25.0% (1/4) | 6.93 | 0.008162 | 0.030094 |
| GO:0033143 | regulation of intracellular steroid hormone receptor signaling pathway | 25.0% (1/4) | 6.93 | 0.008162 | 0.030094 |
| GO:0030308 | negative regulation of cell growth | 50.0% (2/4) | 6.63 | 0.000151 | 0.030176 |
| GO:0047485 | protein N-terminus binding | 25.0% (1/4) | 6.88 | 0.008467 | 0.03084 |
| GO:0051646 | mitochondrion localization | 25.0% (1/4) | 6.88 | 0.008467 | 0.03084 |
| GO:0006606 | protein import into nucleus | 25.0% (1/4) | 6.83 | 0.008772 | 0.031381 |
| GO:0051341 | regulation of oxidoreductase activity | 25.0% (1/4) | 6.83 | 0.008772 | 0.031381 |
| GO:0033120 | positive regulation of RNA splicing | 25.0% (1/4) | 6.85 | 0.00867 | 0.031391 |
| GO:0045934 | negative regulation of nucleobase-containing compound metabolic process | 50.0% (2/4) | 3.64 | 0.009176 | 0.03263 |
| GO:0042826 | histone deacetylase binding | 25.0% (1/4) | 6.7 | 0.009585 | 0.033886 |
| GO:0043489 | RNA stabilization | 25.0% (1/4) | 6.68 | 0.009687 | 0.034045 |
| GO:0098803 | respiratory chain complex | 25.0% (1/4) | 6.67 | 0.009788 | 0.034202 |
| GO:0016236 | macroautophagy | 25.0% (1/4) | 6.61 | 0.010195 | 0.035011 |
| GO:0016363 | nuclear matrix | 25.0% (1/4) | 6.61 | 0.010195 | 0.035011 |
| GO:0043433 | negative regulation of DNA-binding transcription factor activity | 25.0% (1/4) | 6.61 | 0.010195 | 0.035011 |
| GO:0008266 | poly(U) RNA binding | 25.0% (1/4) | 6.6 | 0.010296 | 0.035159 |
| GO:0045926 | negative regulation of growth | 50.0% (2/4) | 5.57 | 0.000653 | 0.035654 |
| GO:0008187 | poly-pyrimidine tract binding | 25.0% (1/4) | 6.54 | 0.010702 | 0.035933 |
| GO:1902369 | negative regulation of RNA catabolic process | 25.0% (1/4) | 6.54 | 0.010702 | 0.035933 |
| GO:1903312 | negative regulation of mRNA metabolic process | 25.0% (1/4) | 6.54 | 0.010702 | 0.035933 |
| GO:0043409 | negative regulation of MAPK cascade | 25.0% (1/4) | 6.51 | 0.010905 | 0.03621 |
| GO:1903008 | organelle disassembly | 25.0% (1/4) | 6.51 | 0.010905 | 0.03621 |
| GO:0033600 | negative regulation of mammary gland epithelial cell proliferation | 25.0% (1/4) | 10.67 | 0.000614 | 0.036894 |
| GO:0060744 | mammary gland branching involved in thelarche | 25.0% (1/4) | 10.67 | 0.000614 | 0.036894 |
| GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis | 25.0% (1/4) | 10.67 | 0.000614 | 0.036894 |
| GO:0045471 | response to ethanol | 25.0% (1/4) | 6.47 | 0.01121 | 0.037016 |
| GO:0051170 | import into nucleus | 25.0% (1/4) | 6.45 | 0.011413 | 0.037277 |
| GO:1902495 | transmembrane transporter complex | 25.0% (1/4) | 6.45 | 0.011413 | 0.037277 |
| GO:0002699 | positive regulation of immune effector process | 25.0% (1/4) | 6.42 | 0.011615 | 0.037331 |
| GO:0010508 | positive regulation of autophagy | 25.0% (1/4) | 6.42 | 0.011615 | 0.037331 |
| GO:0060688 | regulation of morphogenesis of a branching structure | 25.0% (1/4) | 6.42 | 0.011615 | 0.037331 |
| GO:0071897 | DNA biosynthetic process | 25.0% (1/4) | 6.4 | 0.011818 | 0.037383 |
| GO:0005654 | nucleoplasm | 50.0% (2/4) | 3.45 | 0.011758 | 0.037389 |
| GO:0051091 | positive regulation of DNA-binding transcription factor activity | 25.0% (1/4) | 6.41 | 0.011717 | 0.037457 |
| GO:0001819 | positive regulation of cytokine production | 25.0% (1/4) | 6.37 | 0.012021 | 0.037826 |
| GO:0040008 | regulation of growth | 50.0% (2/4) | 3.42 | 0.012365 | 0.038706 |
| GO:0045860 | positive regulation of protein kinase activity | 25.0% (1/4) | 6.31 | 0.012528 | 0.038812 |
| GO:0003730 | mRNA 3'-UTR binding | 25.0% (1/4) | 6.31 | 0.012528 | 0.038812 |
| GO:0002697 | regulation of immune effector process | 25.0% (1/4) | 6.28 | 0.012832 | 0.03955 |
| GO:0019897 | extrinsic component of plasma membrane | 25.0% (1/4) | 6.27 | 0.012934 | 0.039659 |
| GO:1902494 | catalytic complex | 50.0% (2/4) | 3.36 | 0.013282 | 0.040316 |
| GO:0046649 | lymphocyte activation | 25.0% (1/4) | 6.23 | 0.013238 | 0.040385 |
| GO:0042177 | negative regulation of protein catabolic process | 25.0% (1/4) | 6.21 | 0.01344 | 0.040388 |
| GO:0097305 | response to alcohol | 50.0% (2/4) | 3.36 | 0.013377 | 0.0404 |
| GO:1901992 | positive regulation of mitotic cell cycle phase transition | 25.0% (1/4) | 6.19 | 0.013643 | 0.040793 |
| GO:0035239 | tube morphogenesis | 25.0% (1/4) | 6.17 | 0.013845 | 0.041193 |
| GO:0019898 | extrinsic component of membrane | 50.0% (2/4) | 6.04 | 0.000344 | 0.041358 |
| GO:0009895 | negative regulation of catabolic process | 50.0% (2/4) | 5.9 | 0.000414 | 0.04147 |
| GO:0030522 | intracellular receptor signaling pathway | 25.0% (1/4) | 6.13 | 0.01425 | 0.041778 |
| GO:0033674 | positive regulation of kinase activity | 25.0% (1/4) | 6.13 | 0.01425 | 0.041778 |
| GO:0001763 | morphogenesis of a branching structure | 25.0% (1/4) | 6.14 | 0.014149 | 0.04189 |
| GO:0022611 | dormancy process | 25.0% (1/4) | 6.07 | 0.014757 | 0.043052 |
| GO:1990351 | transporter complex | 25.0% (1/4) | 6.06 | 0.014858 | 0.043138 |
| GO:0003714 | transcription corepressor activity | 25.0% (1/4) | 6.02 | 0.015364 | 0.043554 |
| GO:0045321 | leukocyte activation | 25.0% (1/4) | 6.02 | 0.015364 | 0.043554 |
| GO:0031410 | cytoplasmic vesicle | 50.0% (2/4) | 3.26 | 0.015207 | 0.04373 |
| GO:0016043 | cellular component organization | 75.0% (3/4) | 2.2 | 0.015287 | 0.043749 |
| GO:0051701 | biological process involved in interaction with host | 25.0% (1/4) | 6.04 | 0.015161 | 0.043807 |
| GO:0051254 | positive regulation of RNA metabolic process | 50.0% (2/4) | 3.24 | 0.015554 | 0.043888 |
| GO:0031071 | cysteine desulfurase activity | 25.0% (1/4) | 10.93 | 0.000512 | 0.043923 |
| GO:0016554 | cytidine to uridine editing | 25.0% (1/4) | 5.95 | 0.016071 | 0.044511 |
| GO:0008022 | protein C-terminus binding | 25.0% (1/4) | 5.97 | 0.015869 | 0.044567 |
| GO:0098800 | inner mitochondrial membrane protein complex | 25.0% (1/4) | 5.96 | 0.01597 | 0.044643 |
| GO:0097708 | intracellular vesicle | 50.0% (2/4) | 3.22 | 0.016052 | 0.044664 |
| GO:1901989 | positive regulation of cell cycle phase transition | 25.0% (1/4) | 5.92 | 0.016375 | 0.045143 |
| GO:0010494 | cytoplasmic stress granule | 25.0% (1/4) | 5.91 | 0.016577 | 0.045492 |
| GO:0001775 | cell activation | 25.0% (1/4) | 5.9 | 0.016678 | 0.045561 |
| GO:0002009 | morphogenesis of an epithelium | 25.0% (1/4) | 5.85 | 0.017183 | 0.045898 |
| GO:0045931 | positive regulation of mitotic cell cycle | 25.0% (1/4) | 5.85 | 0.017183 | 0.045898 |
| GO:0051246 | regulation of protein metabolic process | 50.0% (2/4) | 3.17 | 0.0171 | 0.046085 |
| GO:0010557 | positive regulation of macromolecule biosynthetic process | 50.0% (2/4) | 3.18 | 0.017024 | 0.046087 |
| GO:1990221 | L-cysteine desulfurase complex | 25.0% (1/4) | 11.67 | 0.000307 | 0.046123 |
| GO:0016553 | base conversion or substitution editing | 25.0% (1/4) | 5.87 | 0.016981 | 0.046179 |
| GO:1990204 | oxidoreductase complex | 25.0% (1/4) | 5.84 | 0.017385 | 0.046232 |
| GO:0045935 | positive regulation of nucleobase-containing compound metabolic process | 50.0% (2/4) | 3.13 | 0.0181 | 0.047091 |
| GO:0014069 | postsynaptic density | 25.0% (1/4) | 5.8 | 0.01789 | 0.047158 |
| GO:0099572 | postsynaptic specialization | 25.0% (1/4) | 5.8 | 0.01789 | 0.047158 |
| GO:0031099 | regeneration | 25.0% (1/4) | 5.76 | 0.018294 | 0.047187 |
| GO:0009986 | cell surface | 25.0% (1/4) | 5.78 | 0.018092 | 0.047275 |
| GO:1900865 | chloroplast RNA modification | 25.0% (1/4) | 5.78 | 0.018092 | 0.047275 |
| GO:0071840 | cellular component organization or biogenesis | 75.0% (3/4) | 2.11 | 0.018283 | 0.047364 |
| GO:0001817 | regulation of cytokine production | 25.0% (1/4) | 5.72 | 0.018798 | 0.04767 |
| GO:0043410 | positive regulation of MAPK cascade | 25.0% (1/4) | 5.72 | 0.018798 | 0.04767 |
| GO:0048024 | regulation of mRNA splicing, via spliceosome | 25.0% (1/4) | 5.72 | 0.018899 | 0.047725 |
| GO:0051128 | regulation of cellular component organization | 50.0% (2/4) | 3.11 | 0.018665 | 0.047734 |
| GO:0030424 | axon | 25.0% (1/4) | 5.74 | 0.018597 | 0.047763 |
| GO:0009536 | plastid | 50.0% (2/4) | 3.08 | 0.019286 | 0.048295 |
| GO:0031982 | vesicle | 50.0% (2/4) | 3.08 | 0.019238 | 0.048376 |
| GO:0051345 | positive regulation of hydrolase activity | 25.0% (1/4) | 5.68 | 0.019404 | 0.048388 |
| GO:0031324 | negative regulation of cellular metabolic process | 50.0% (2/4) | 3.07 | 0.01964 | 0.048776 |